|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar
|
|
2
|
Zhang J, Jiang Y, Zhu J, Wu T, Ma J, Du C,
Chen S, Li T, Han J and Wang X: Overexpression of long non-coding
RNA colon cancer-associated transcript 2 is associated with
advanced tumor progression and poor prognosis in patients with
colorectal cancer. Oncol Lett. 14:6907–6914. 2017.
|
|
3
|
Simon K: Colorectal cancer development and
advances in screening. Clin Interv Aging. 11:967–976. 2016.
View Article : Google Scholar
|
|
4
|
Bach DH and Lee SK: Long noncoding RNAs in
cancer cells. Cancer Lett. 419:152–166. 2018. View Article : Google Scholar
|
|
5
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar
|
|
6
|
Huang JL, Cao SW, Ou QS, Yang B, Zheng SH,
Tang J, Chen J, Hu YW, Zheng L and Wang Q: The long non-coding RNA
PTTG3P promotes cell growth and metastasis via up-regulating PTTG1
and activating PI3K/AKT signaling in hepatocellular carcinoma. Mol
Cancer. 17:932018. View Article : Google Scholar
|
|
7
|
Zheng S, Chen H, Wang Y, Gao W, Fu Z, Zhou
Q, Jiang Y, Lin Q, Tan L, Ye H, et al: Long non-coding RNA
LOC389641 promotes progression of pancreatic ductal adenocarcinoma
and increases cell invasion by regulating E-cadherin in a
TNFRSF10A-related manner. Cancer Lett. 371:354–365. 2016.
View Article : Google Scholar
|
|
8
|
Zhang M, Duan W and Sun W: LncRNA SNHG6
promotes the migration, invasion, and epithelial-mesenchymal
transition of colorectal cancer cells by miR-26a/EZH2 axis.
OncoTargets Ther. 12:3349–3360. 2019. View Article : Google Scholar
|
|
9
|
Zhan HX, Wang Y, Li C, Xu JW, Zhou B, Zhu
JK, Han HF, Wang L, Wang YS and Hu SY: LincRNA-ROR promotes
invasion, metastasis and tumor growth in pancreatic cancer through
activating ZEB1 pathway. Cancer Lett. 374:261–271. 2016. View Article : Google Scholar
|
|
10
|
Kong F, Deng X, Kong X, Du Y, Li L, Zhu H,
Wang Y, Xie D, Guha S, Li Z, et al: ZFPM2-AS1, a novel lncRNA,
attenuates the p53 pathway and promotes gastric carcinogenesis by
stabilizing MIF. Oncogene. 37:5982–5996. 2018. View Article : Google Scholar
|
|
11
|
Xue M, Tao W, Yu S, Yan Z, Peng Q, Jiang F
and Gao X: lncRNA ZFPM2-AS1 promotes proliferation via
miR-18b-5p/VMA21 axis in lung adenocarcinoma. J Cell Biochem.
121:313–321. 2020. View Article : Google Scholar
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
13
|
Duan X, Kong Z, Liu Y, Zeng Z, Li S, Wu W,
Ji W, Yang B, Zhao Z and Zeng G: β-Arrestin2 contributes to cell
viability and proliferation via the down-regulation of FOXO1 in
castration-resistant prostate cancer. J Cell Physiol.
230:2371–2381. 2015. View Article : Google Scholar
|
|
14
|
Gao R, Fang C, Xu J, Tan H, Li P and Ma L:
LncRNA CACS15 contributes to oxaliplatin resistance in colorectal
cancer by positively regulating ABCC1 through sponging miR-145.
Arch Biochem Biophys. 663:183–191. 2019. View Article : Google Scholar
|
|
15
|
Xu Y, Zhang X, Hu X, Zhou W, Zhang P,
Zhang J, Yang S and Liu Y: The effects of lncRNA MALAT1 on
proliferation, invasion and migration in colorectal cancer through
regulating SOX9. Mol Med. 24:522018. View Article : Google Scholar
|
|
16
|
Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K,
Liu X, Xu T, Sun L, Qin J, et al: LncRNA SATB2-AS1 inhibits tumor
metastasis and affects the tumor immune cell microenvironment in
colorectal cancer by regulating SATB2. Mol Cancer. 18:1352019.
View Article : Google Scholar
|
|
17
|
Ge X, Li GY, Jiang L, Jia L, Zhang Z, Li
X, Wang R, Zhou M, Zhou Y, Zeng Z, et al: Long noncoding RNA CAR10
promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis.
Oncogene. 38:3061–3076. 2019. View Article : Google Scholar
|
|
18
|
Yang H, Liu P, Zhang J, Peng X, Lu Z, Yu
S, Meng Y, Tong WM and Chen J: Long noncoding RNA MIR31HG exhibits
oncogenic property in pancreatic ductal adenocarcinoma and is
negatively regulated by miR-193b. Oncogene. 35:3647–3657. 2016.
View Article : Google Scholar
|
|
19
|
Chen L, Wang X, Wang H, Li Y, Yan W, Han
L, Zhang K, Zhang J, Wang Y, Feng Y, et al: miR-137 is frequently
down-regulated in glioblastoma and is a negative regulator of
Cox-2. Eur J Cancer. 48:3104–3111. 2012. View Article : Google Scholar
|
|
20
|
Li X, Chen W, Zeng W, Wan C, Duan S and
Jiang S: microRNA-137 promotes apoptosis in ovarian cancer cells
via the regulation of XIAP. Br J Cancer. 116:66–76. 2017.
View Article : Google Scholar
|
|
21
|
Peres J, Kwesi-Maliepaard EM, Rambow F,
Larue L and Prince S: The tumour suppressor, miR-137, inhibits
malignant melanoma migration by targetting the TBX3 transcription
factor. Cancer Lett. 405:111–119. 2017. View Article : Google Scholar
|
|
22
|
Sun L, Liang J, Wang Q, Li Z, Du Y and Xu
X: MicroRNA-137 suppresses tongue squamous carcinoma cell
proliferation, migration and invasion. Cell Prolif. 49:628–635.
2016. View Article : Google Scholar
|
|
23
|
Miao H, Wang N, Shi LX, Wang Z and Song
WB: Overexpression of mircoRNA-137 inhibits cervical cancer cell
invasion, migration and epithelial-mesenchymal transition by
suppressing the TGF-β/smad pathway via binding to GREM1. Cancer
Cell Int. 19:1472019. View Article : Google Scholar
|
|
24
|
Balaguer F, Link A, Lozano JJ, Cuatrecasas
M, Nagasaka T, Boland CR and Goel A: Epigenetic silencing of
miR-137 is an early event in colorectal carcinogenesis. Cancer Res.
70:6609–6618. 2010. View Article : Google Scholar
|
|
25
|
Zhang LH, Yin AA, Cheng JX, Huang HY, Li
XM, Zhang YQ, Han N and Zhang X: TRIM24 promotes glioma progression
and enhances chemoresistance through activation of the PI3K/Akt
signaling pathway. Oncogene. 34:600–610. 2015. View Article : Google Scholar
|
|
26
|
Lv D, Li Y, Zhang W, Alvarez AA, Song L,
Tang J, Gao WQ, Hu B, Cheng SY and Feng H: TRIM24 is an oncogenic
transcriptional co-activator of STAT3 in glioblastoma. Nat Commun.
8:14542017. View Article : Google Scholar
|
|
27
|
Zhu Y, Zhao L, Shi K, Huang Z and Chen B:
TRIM24 promotes hepatocellular carcinoma progression via AMPK
signaling. Exp Cell Res. 367:274–281. 2018. View Article : Google Scholar
|
|
28
|
Wang FQ, Han Y, Yao W and Yu J: Prognostic
relevance of tripartite motif containing 24 expression in
colorectal cancer. Pathol Res Pract. 213:1271–1275. 2017.
View Article : Google Scholar
|
|
29
|
Wang J, Zhu J, Dong M, Yu H, Dai X and Li
K: Knockdown of tripartite motif containing 24 by lentivirus
suppresses cell growth and induces apoptosis in human colorectal
cancer cells. Oncol Res. 22:39–45. 2014. View Article : Google Scholar
|
